Brendan
Studebaker
VP Of Operations
Brendan Studebaker is a career biologist with experience building advanced therapeutic platforms and digital laboratory infrastructures for biotech organizations. He brings a rare combination of bench-level scientific expertise, operational leadership, and systems design. At Onnix, he applies this background to support the development and operational readiness of the company’s EDTA-based catheter lock/flush solution.
Prior to joining the company, Brendan led cell line engineering and molecular biology programs at Link Cell Therapies, a CAR-T company developing solid-tumor therapies using GATE logic technology. He also contributed to gene-editing platform development at Graphite Bio and supported antibody discovery initiatives at Just–Evotec Biologics, working across vector design, molecular engineering, and the digital systems that enable modern R&D teams to operate efficiently and reliably.
His background allows him to bridge technical execution with operational structure, ensuring that scientific programs are carried out with consistency, traceability, and scalability.
At Onnix, Brendan supports operations, scientific coordination, and systems implementation as the company advances its EDTA-based catheter lock/flush solution toward clinical evaluation.
Jared
Navarre
Chief Executive Officer
Jared Navarre is a high-IQ strategist and operational architect who has founded, scaled, and led numerous successful companies across healthcare, infrastructure, real estate, logistics, and creative sectors. With a verified IQ of 156 on the WAIS-IV, he is widely regarded as one of the most effective leaders and problem-solvers in business — known for bringing order to complexity and translating fragmented systems into aligned strategy, execution, and growth. Navarre is often brought in to lead high-stakes transitions and unlock stalled momentum at the leadership and board level.
He is the founder and CEO of Keyni, a consultancy that has advised over 250 companies — including Fortune 50 firms and mid-market operators — across technology, healthcare, infrastructure, and finance. His clients include Microsoft, Steris, Capital One, Reebok, Adobe, HCA Healthcare, and the City of Atlanta.
Navarre currently owns and operates ventures in real estate, logistics, and field services, including JPACK, Rock Solid Plumbing & Heating, VONA, and Potluck Lunch Records, and has held C-suite roles in over 15 companies. He sold his first IT firm at age 17 and has since built a reputation as a trusted advisor to boards and executive teams navigating high-stakes transitions.
Brendan Studebaker is a career biologist with experience building advanced therapeutic platforms and digital laboratory infrastructures for biotech organizations. He brings a rare combination of bench-level scientific expertise, operational leadership, and systems design. At Onnix, he applies this background to support the development and operational readiness of the company’s EDTA-based catheter lock/flush solution.
Prior to joining the company, Brendan led cell line engineering and molecular biology programs at Link Cell Therapies, a CAR-T company developing solid-tumor therapies using GATE logic technology. He also contributed to gene-editing platform development at Graphite Bio and supported antibody discovery initiatives at Just–Evotec Biologics, working across vector design, molecular engineering, and the digital systems that enable modern R&D teams to operate efficiently and reliably.
His background allows him to bridge technical execution with operational structure, ensuring that scientific programs are carried out with consistency, traceability, and scalability.
At Onnix, Brendan supports operations, scientific coordination, and systems implementation as the company advances its EDTA-based catheter lock/flush solution toward clinical evaluation.
